ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2017
Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD.
Daniel A Gerardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.